Durrbach A - Search Results

1

Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients.

Wiedemann A, Pellaton C, Dekeyser M, Guillaumat L, Déchenaud M, Krief C, Lacabaratz C, Grimbert P, Pantaleo G, Lévy Y, Durrbach A. Wiedemann A, et al. Among authors: durrbach a. Front Med (Lausanne). 2022 Aug 22;9:978764. doi: 10.3389/fmed.2022.978764. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36072955 Free PMC article.

2

Risk factors and long-term outcome of transplant renal artery stenosis in adult recipients after treatment by percutaneous transluminal angioplasty.

Audard V, Matignon M, Hemery F, Snanoudj R, Desgranges P, Anglade MC, Kobeiter H, Durrbach A, Charpentier B, Lang P, Grimbert P. Audard V, et al. Among authors: durrbach a. Am J Transplant. 2006 Jan;6(1):95-9. doi: 10.1111/j.1600-6143.2005.01136.x. Am J Transplant. 2006. PMID: 16433762 Free article.

3

Comparison of 3 estimation methods of mycophenolic acid AUC based on a limited sampling strategy in renal transplant patients.

Hulin A, Blanchet B, Audard V, Barau C, Furlan V, Durrbach A, Taïeb F, Lang P, Grimbert P, Tod M. Hulin A, et al. Among authors: durrbach a. Ther Drug Monit. 2009 Apr;31(2):224-32. doi: 10.1097/FTD.0b013e31819c077c. Ther Drug Monit. 2009. PMID: 19214145

4

T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade.

Grimbert P, Audard V, Diet C, Matignon M, Plonquet A, Mansour H, Desvaux D, Durrbach A, Cohen JL, Lang P. Grimbert P, et al. Among authors: durrbach a. Nephrol Dial Transplant. 2011 Mar;26(3):1087-93. doi: 10.1093/ndt/gfq453. Epub 2010 Jul 28. Nephrol Dial Transplant. 2011. PMID: 20667993 Clinical Trial.

5

Prognostic significance of graft Foxp3 expression in renal transplant recipients: a critical review and attempt to reconcile discrepancies.

Zuber J, Grimbert P, Blancho G, Thaunat O, Durrbach A, Baron C, Lebranchu Y. Zuber J, et al. Among authors: durrbach a. Nephrol Dial Transplant. 2013 May;28(5):1100-11. doi: 10.1093/ndt/gfs570. Epub 2012 Dec 21. Nephrol Dial Transplant. 2013. PMID: 23262436 Review.

6

Polyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy?

Dekeyser M, François H, Beaudreuil S, Durrbach A. Dekeyser M, et al. Among authors: durrbach a. Front Immunol. 2015 Jun 16;6:307. doi: 10.3389/fimmu.2015.00307. eCollection 2015. Front Immunol. 2015. PMID: 26136745 Free PMC article. Review.

7

B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.

Delville M, Baye E, Durrbach A, Audard V, Kofman T, Braun L, Olagne J, Nguyen C, Deschênes G, Moulin B, Delahousse M, Kesler-Roussey G, Beaudreuil S, Martinez F, Rabant M, Grimbert P, Gallazzini M, Terzi F, Legendre C, Canaud G. Delville M, et al. Among authors: durrbach a. J Am Soc Nephrol. 2016 Aug;27(8):2520-7. doi: 10.1681/ASN.2015091002. Epub 2015 Dec 23. J Am Soc Nephrol. 2016. PMID: 26701979 Free PMC article.

8

Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy.

Dekeyser M, de Goër de Herve MG, Hendel-Chavez H, Labeyrie C, Adams D, Nasser GA, Gasnault J, Durrbach A, Taoufik Y. Dekeyser M, et al. Among authors: durrbach a. Open Forum Infect Dis. 2017 May 16;4(2):ofx100. doi: 10.1093/ofid/ofx100. eCollection 2017 Spring. Open Forum Infect Dis. 2017. PMID: 28638849 Free PMC article.

9

Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR).

Leibler C, Matignon M, Moktefi A, Samson C, Zarour A, Malard S, Boutin E, Pilon C, Salomon L, Natella PA, Durrbach A, Robert T, Canoui-Poitrine F, Grimbert P. Leibler C, et al. Among authors: durrbach a. Am J Transplant. 2019 Mar;19(3):894-906. doi: 10.1111/ajt.15229. Epub 2019 Jan 25. Am J Transplant. 2019. PMID: 30582270 Free article.

10

Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE trial.

Matignon M, Lelièvre JD, Lahiani A, Abbassi K, Desvaux D, Diallo A, Peraldi MN, Taburet AM, Saillard J, Delaugerre C, Costagliola D, Assoumou L, Grimbert P; ANRS 153 TREVE study group. Matignon M, et al. HIV Med. 2019 Mar;20(3):202-213. doi: 10.1111/hiv.12700. Epub 2019 Jan 27. HIV Med. 2019. PMID: 30688008 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters